Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
Automated microscopy and Spatial Proteomics
Automated microscopy and image analysis
Discover
Related topics
Mar 22, 2024
Mission Bio’s Tapestri Tool May Hold the Key to Informing Treatment Options for Multiple Myeloma.
Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)
Feb 7, 2024
Samples from 82 patients with NSCLC and matched pre- and post-ICI biopsies were subjected to genomic profiling and to...
Introducing The Cytek Orion: Reagent Cocktail Preparation System
Jan 29, 2024
Cytek is proud to announce the Cytek Orion reagent cocktail preparation system. The Cytek Orion system allows for...
Meet new Analytik Jena qTOWERiris series
Jan 19, 2024
Thanks to a very precise thermoblock made of silver and the use of a unique, super-fast and very accurate optical...
Small animal DXA instrument comparison and validation 2024
Jan 8, 2024
This study evaluated the performance of two relatively new peripheral bone densitometry machines, the InAlyzer and the...
Flexible multiplex panel design with new Orion Reagents
Jan 5, 2024
Orion Reagents are tailored to enable spatial biomarker quantitation rapidly, easily and with maximum flexibility....
ScanDrop² Series: Maximum Flexibility in Micro-Volume
Nov 6, 2023
The ScanDrop2 from Analytik Jena is the second generation of microvolume spectrophotometers. It´s innovative Butterfly...
Drive key insights and discoveries with NEW Live Cell Analysis applications for eSight system
Aug 2, 2023
eSight is now powerful like never before. Learn more about new dedicated application modules for live-cell analysis: 3D...
High speed, compact and fully automated microscope inside your incubator? Lumascope850
Jul 13, 2023
The powerful, new LS850 Microscope is the latest generation of our fully automated three-channel flagship model and...
InAlyzer - The technology chosen by NASA
Jul 10, 2023
MEDIKORS's InAlyzer was finally selected as the equipment to be used for NASA's space environment biological research
Aug 1, 2016
ACEA Biosciences, a pioneer in the development of high performance cell analysis platforms including the xCELLigence Real-Time Cell Analyzer (RTCA) instruments and NovoCyte flow cytometers, is introducing an immunotherapy kit for in vitro monitoring and quantification of effector-mediated B cell killing. This kit enables continuous real-time monitoring of B cell lymphomas as they are exposed to diverse immunotherapy approaches including NK cells, T cells, CARTs, oncolytic virus, checkpoint inhibitors, bispecific antibodies, BiTEs, etc. The major distinguishing features of this technology include enhanced sensitivity, the preclusion of labels, simple workflow and, importantly, continuous kinetic measurement of B cell cytolysis. This B cell-specific kit is the first in a series of xCELLigence immunotherapy-focused kits that ACEA will be launching in the coming months.
The utility of impedance-based xCELLigence Real-Time Cell Analysis (RTCA) for probing the efficacy of immunotherapies targeting solid/adherent cancers has been firmly established over the past decade. However, ~10% of all cancers are liquid in nature, are non-adherent and therefore cannot be directly monitored by the standard impedance assay. The B Cell Killing Assay Kit contains reagents which enable B cells to be selectively immobilized in the well bottoms of ACEA’s electronic microtiter plates. Addition of effector cells (NK, T, CART) on top of immobilized B cells results in cytolysis of target cells in an effector concentration-dependent manner. The continuous acquisition of impedance data for each well of the electronic plate allows the generation of real-time killing curves for multiple conditions simultaneously.
Dr. Yama Abassi, Vice President of ACEA Biosciences, noted that “The xCELLigence instruments provide a quantitative kinetic assessment of immune cell-mediated killing of both solid and liquid tumor cells under label-free conditions.” He further stated that “This functional assay is currently being used for evaluating/optimizing combination therapies, and for the development of adoptive cell therapies and engineered antibodies. Beyond the arena of R&D, we envision xCELLigence being utilized as a quality control assay for manufactured immuno-oncology therapies.”
Related technologies: Conventional flow cytometry
Brand profile
Agilent provides xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com